sam.directory home Get Started
Contacts, documents and full notice history are available with a subscription.
Create free account Log in
Award Notice SBA 1 notice

Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract 75F40124R00064

Solicitation 75F40124R00064 Copied Notice ID b5f18d924b64480295b9816059860a6e Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FDA OFFICE OF ACQ GRANT SVCS
SAM.gov
Posted
Sep 16, 2025
Deadline
No deadline
Set-aside
SBA
NAICS
541714
PSC
AJ12

Summary

AI-generated · Sep 17, 2025

Provide multi-phase, multi-site clinical studies and laboratory support under an indefinite-delivery/indefinite-quantity contract for FDA’s clinical pharmacology program. The contractor must be able to conduct multiple Phase I clinical trials within a year, including running some trials in parallel, and deliver a full range of services to execute the trials and report the results, along with the associated laboratory support.

All task orders under the IDIQ are firm-fixed-price. The arrangement covers clinical operations, laboratory testing, and related data management and reporting to support the conduct and completion of the trials across sites.

This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).

From Award Notice posted on Sep 16, 2025

Notice history

1
  1. Award Notice LATEST Posted Sep 16, 2025
View Solicitation Overview

Details

Solicitation number 75F40124R00064
Notice ID b5f18d924b64480295b9816059860a6e
Award number 75F40125D00003
Notice type Award Notice
Product / Service (PSC) AJ12
NAICS 541714
Set-aside Total Small Business Set-Aside (FAR 19.5)
Place of performance Texas
Archive date Sep 30, 2025

Award Information

Awardee
1
Total Awarded
$50,000,000.00
Award Date
Sep 15, 2025

Award Notices

Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract View Notice

Posted: Sep 16, 2025

This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I...

Awardees

Company Name UEI CAGE Code Location
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC FWWJT8QCEDY4 9Z4C3 Webster, TX

Documents

No files available

View on SAM.gov

Contacts

primary
Craig Wright

Email

Phone

secondary
Ian Weiss

Email

Phone

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FOOD AND DRUG ADMINISTRATION
FDA OFFICE OF ACQ GRANT SVCS

Place of Performance

Texas 77598
USA

Dates

Posted Sep 16, 2025 10 months ago
Last Updated Aug 06, 2026 2 days ago
Awarded Sep 15, 2025 10 months ago